News

Keep up with the latest news from the NCI Center for Biomedical Informatics and Information Technology (CBIIT) and the data science communities.

NIH released this RFI to inform the development of consent language for data and biospecimen sharing.

NCI's Cancer Research Data Commons’ Proteomic Data Commons has released accompanying proteomic data from the Clinical Proteomic Tumor Analysis Consortium Acute Myeloid Leukemia study.

This RFI will inform the development of an NIH initiative on the use of Artificial Intelligence/Machine Learning to address health disparities and inequities and enhance diversity within the AI/ML workforce.

NCI's Cancer Research Data Commons’ Imaging Data Commons has recently been featured in the official journal of the American Association for Cancer Research.

NCI's Cancer Research Data Commons’ Imaging Data Commons has added new imaging data from The Cancer Imaging Archive in its latest update.

NCI Director Dr. Ned Sharpless and CBIIT Director Dr. Tony Kerlavage recently published an article, “The Potential of AI in Cancer Care and Research,” which takes stock of current advances in artificial intelligence and machine learning and outlines some of the areas NCI hopes to explore in greater depth in the future.

On June 21–24, 2021, in partnership with the Howard University Research Centers for Minority Institutions Program, the NIH Office of Data Science Strategy is hosting a virtual codeathon for addressing health disparities. Applications to participate are due Monday, June 7, 2021.

Beginning with an “analysis-first” approach, the Bridge2AI program values the machine-understandability of data and incorporates ethical principles surrounding data collection and use. See the list of upcoming June events and funding opportunities affiliated with the program.

NCI’s Office of Cancer Clinical Proteomics Research is looking for two scientists to support the Clinical Proteomic Tumor Analysis Consortium either through proteomics data science/management (which will include coordinating with CBIIT) or biospecimen procurement/management. Applications for these vacancies may be submitted until Wednesday, May 26, 2021.

Apply by June 8 to participate in NCI’s DataViz + Cancer Innovation Lab and join a diverse team in the search for creative ways to build a patient-centered clinical experience.